News
16h
News-Medical.Net on MSNMapping the T cell response to Chikungunya virusA new study, published recently in Nature Communications, offers the first-ever map of which parts of Chikungunya virus ...
Studies undertaken by researchers at Queen Mary and University of Konstanz have identified a critical chemical signal in the ...
The ability to analyze gene expression at the single-cell level—known as single-cell RNA sequencing (scRNA-seq)—has ...
3d
Dealbreaker on MSNAbbVie’s $2.1B Acquisition Adds In Vivo Cell Therapy to Its Immunology & Inflammation PipelineAbbVie is acquiring Capstan Therapeutics, a startup with technology that enables in vivo engineering of immune cells.
A new study, published recently in Nature Communications , offers the first-ever map of which parts of Chikungunya virus trigger the ...
AbbVie said on Monday it would acquire privately held cell therapy developer Capstan Therapeutics in a deal worth up to $2.1 ...
An engineered protein turns off the kind of immune cells most likely to damage tissue as part of type 1 diabetes, hepatitis ...
AbbVie has announced that it will be expanding its immunology capabilities by acquiring Capstan Therapeutics for up to $2.1bn ...
LJI scientists have discovered that T cells may help detect Parkinson's disease years before motor symptoms appear. Your T ...
At first glance, some people seem to have recovered from COVID-19. They no longer test positive and can return to work or ...
Scientists at UC Davis discovered a small genetic difference that could explain why humans are more prone to certain cancers ...
4d
Stocktwits on MSNAbbVie To Acquire Capstan Therapeutics For Up To $2.1 Billion To Boost Immunology Portfolio As Humira Sales Drop: Stock Gains In Morning TradeAbbVie (ABBV) on Monday announced that it has entered into a definitive agreement to acquire privately held clinical-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results